BRIEF-Coherus Biosciences presents study results demonstrating equivalence of CHS-0214 biosimilar to Etanercept

Coherus Biosciences Inc: * Coherus provides research study results showing equivalence
of its CHS-0214 biosimilar to etanercept

* Results of research study showed equivalence of CHS-0214 to
etanercept with regard to efficacy as determined by a main
endpoint

* There were no clinically significant distinctions in between
CHS-0214 and etanercept with regard to safety and immunogenicity

* Secondary endpoints supported equivalence of CHS-0214 to
etanercept

Source text for Eikon:
More company coverage:

( Bengaluru Newsroom: +1 646 223 8780).

Read More

Leave a Reply

Your email address will not be published. Required fields are marked *